Lifeward (NASDAQ:LFWD – Get Free Report) and GN Store Nord (OTCMKTS:GNNDY – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.
Risk and Volatility
Lifeward has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, GN Store Nord has a beta of 1.74, indicating that its share price is 74% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent recommendations for Lifeward and GN Store Nord, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lifeward | 1 | 1 | 2 | 0 | 2.25 |
| GN Store Nord | 1 | 2 | 2 | 0 | 2.20 |
Lifeward presently has a consensus price target of $10.00, suggesting a potential upside of 71.53%. Given Lifeward’s stronger consensus rating and higher possible upside, research analysts plainly believe Lifeward is more favorable than GN Store Nord.
Profitability
This table compares Lifeward and GN Store Nord’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Lifeward | -141.28% | -235.86% | -81.72% |
| GN Store Nord | -2.50% | -2.01% | -0.72% |
Earnings and Valuation
This table compares Lifeward and GN Store Nord”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Lifeward | $21.82 million | 0.76 | -$19.91 million | ($16.82) | -0.35 |
| GN Store Nord | $2.54 billion | 1.06 | $98.86 million | ($0.90) | -59.56 |
GN Store Nord has higher revenue and earnings than Lifeward. GN Store Nord is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
26.8% of Lifeward shares are held by institutional investors. 1.1% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
GN Store Nord beats Lifeward on 8 of the 13 factors compared between the two stocks.
About Lifeward
Lifeward Ltd. (NASDAQ: LFWD) is a medical technology company focused on developing and commercializing wearable robotic systems designed to help people with mobility impairments stand, walk and participate in rehabilitation. The company was formerly known as ReWalk Robotics and adopted the Lifeward name in 2024. Lifeward’s principal product line is the ReWalk Personal Exoskeleton, a battery-powered wearable robotic device intended to enable individuals with lower-limb disabilities, including those resulting from spinal cord injury, to walk with the assistance of crutches or other support.
About GN Store Nord
GN Store Nord is a Denmark-based company that develops hearing, audio and communications products. Its business includes hearing aids and related solutions, as well as headsets and other audio equipment for professional and personal use. Its brands include ReSound and Beltone in hearing care, and Jabra and BlueParrott in audio and communications. Products serve consumers and organizations across areas such as healthcare, business communications and professional driving. The company traces its roots to the Great Northern Telegraph Company, founded in 1869, and is headquartered in Ballerup, Denmark.
Receive News & Ratings for Lifeward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeward and related companies with MarketBeat.com's FREE daily email newsletter.
